Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

• Published in: International journal of molecular sciences Vol. 23; no. 2; p. 786
• Main Authors: Fahed, Gracia, Aoun, Laurence, Bou Zerdan, Morgan, Allam, Sabine, Bou Zerdan, Maroun, Bouferraa, Youssef, Assi, Hazem I.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 12.01.2022; MDPI
• Subjects: Abdomen; Biomarkers; Blood pressure; Body fat; Cholesterol; Chronic Disease; Diabetes; Disease; Disease Management; Disease Susceptibility; Epidemiology; Glucose; High density lipoprotein; Hormones; Humans; Hypertension; Inflammation - complications; Inflammation - etiology; Inflammation - metabolism; Insulin Resistance; Lipoproteins; Liver; Metabolic syndrome; Metabolic Syndrome - diagnosis; Metabolic Syndrome - etiology; Metabolic Syndrome - metabolism; Metabolic Syndrome - therapy; Mitochondria - genetics; Mitochondria - metabolism; Obesity; Organ Specificity; Pathophysiology; Prevalence; Public Health Surveillance; Review; Womens health; United States > US; metabolic syndrome; insulin resistance; nutraceuticals

Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis of MetS encompasses multiple genetic and acquired entities that fall under the umbrella of insulin resistance and chronic...